Cowen Prime Advisors’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-181
Closed -$32K 235
2020
Q1
$32K Hold
181
0.02% 127
2019
Q4
$35K Hold
181
0.02% 124
2019
Q3
$30K Hold
181
0.02% 123
2019
Q2
$30K Hold
181
0.01% 129
2019
Q1
$27K Hold
181
0.01% 135
2018
Q4
$24K Hold
181
0.01% 142
2018
Q3
$34K Hold
181
0.02% 154
2018
Q2
$30K Hold
181
0.01% 160
2018
Q1
$30K Hold
181
0.02% 156
2017
Q4
$30K Hold
181
0.01% 157
2017
Q3
$37K Hold
181
0.02% 141
2017
Q2
$44K Hold
181
0.02% 140
2017
Q1
$43K Buy
181
+5
+3% +$1.16K 0.02% 141
2016
Q4
$37K Sell
176
-1,988
-92% -$412K 0.02% 140
2016
Q3
$498K Buy
2,164
+400
+23% +$97.7K 0.23% 73
2016
Q2
$408K Sell
1,764
-2,647
-60% -$610K 0.2% 72
2016
Q1
$1.18M Buy
4,411
+5
+0.1% +$1.43K 0.55% 37
2015
Q4
$1.38M Buy
4,406
+3,198
+265% +$952K 0.61% 33
2015
Q3
$328K Hold
1,208
0.15% 78
2015
Q2
$367K Hold
1,208
0.14% 77
2015
Q1
$360K Buy
+1,208
New +$344K 0.15% 83
2014
Q4
Sell
-767
Closed -$185K 332
2014
Q3
$185K Buy
+767
New +$172K 0.08% 110
2014
Q1
Sell
-964
Closed -$162K 302
2013
Q4
$162K Buy
+964
New +$151K 0.06% 115

Other funds holding AGN

Cowen Prime Advisors's AGN Position: Q2 2020 in Review

Cowen Prime Advisors sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 181 shares — an estimated $32K sold.

Cowen Prime Advisors first reported a position in AGN in Q4 2013 and held it in 23 quarters. The position peaked at $1.38M in Q4 2015. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Cowen Prime Advisors reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Cowen Prime Advisors sold 181 Allergan plc shares in Q2 2020, an estimated $32K.
  • Cowen Prime Advisors first reported a position in Allergan plc in Q4 2013 and held it in 23 quarters.
  • Cowen Prime Advisors's Allergan plc position peaked at $1.38M in Q4 2015.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Cowen Prime Advisors's 13F filing for Q2 2020, filed 29 Jul 2020.